ClinicoEconomics and outcomes research : CEOR

Keyphrases

Publications

volume 16, 2024

Abdulmajeed Alshowair, Saleh Altamimi, Faisal A Alruhaimi, Saad Alshahrani, Fatima Alsuwailem, Mona Alkhaldi, Haiam Abdalla, Fahad Hamad Alkhuraiji, Montaser Saad Alaqeel, Salman Sulaiman Almureef, Salman Alhawasy, Amro Abdel-Azeem
Cost-Savings Associated with Multi-Disciplinary Team Approach for Reducing Macrovascular and Microvascular Complications in Patients with Type 2 Diabetes: A Predictive Model. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Amrizal Muhammad Nur, Syed Mohamed Aljunid, Mohammad Almari
The Economic Burden of the COVID-19 Pandemic in State of Kuwait. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Kevin C J Yuen, Lewis S Blevins, David R Clemmons, Mads Faurby, Andrew R Hoffman, Nicky Kelepouris, Janice M Kerr, Jens Magelund Tarp, Maria Fleseriu
Medical Costs Associated with High/Moderate/Low Likelihood of Adult Growth Hormone Deficiency: A Healthcare Claims Database Analysis. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Farid Samaan, Áquilas Mendes, Leonardo Carnut
Privatization and Oligopolies of the Renal Replacement Therapy Sector on Contemporary Capitalism: A Systematic Review and the Brazilian Scenario. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Jason Robert Guertin, Mahée Gilbert-Ouimet, Michèle Dugas, Valérie Carnovale, Laura Jalbert, Olha Svyntozelska, Juliette Demers, Léonie Matteau, Frédéric Bergeron, Annie LeBlanc
Methods used to account for caregivers' sex and gender within studies examining the financial burden of caregivers of children and adolescents : Results from a scoping review. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Sergio Di Matteo, Roberto Freilone, Giacomo Matteo Bruno, Rosario Notaro, Sabrin Moumene, Nicoletta Martone, Cristina Teruzzi, Antonio Ciccarone, Giorgio Lorenzo Colombo
Cost-Utility Analysis Comparing Pegcetacoplan to Anti-C5 Monoclonal Antibodies in the Treatment of Paroxysmal Nocturnal Hemoglobinuria. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Rami A Al-Dwairi, Abdelwahab Aleshawi, Laith Abu-Zreig, Wafa Al-Shorman, Seren Al Beiruti, Ali Omar Alshami, Mohammed Z Allouh
The Economic Burden of Diabetic Retinopathy in Jordan: Cost Analysis and Associated Factors. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Krithika Rajagopalan, Nazia Rashid, Vinod Yakkala, Dilesh Doshi
Analysis of Medicare Patients Treated with Pimavanserin versus Other Atypical Antipsychotics: A Cost-Offset Model Evaluating Skilled Nursing Facility Stays and Long-Term Care Admissions in Parkinson's Disease Psychosis. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Malvina Hoxha, Visar Malaj, Bruno Zappacosta, Najada Firza
Pharmacoeconomic Evaluation of Costs of Myelomeningocele and Meningocele Treatment and Screening. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Ralph H B Benedict, Pamela Vo, Nicholas Adlard, Olwyn Grennan, Ashley Enstone, Daisy Bridge, Robin Wyn, Stanley L Cohan
Disutility of Cognitive Processing Speed (CPS) Impairment in the Context of Multiple Sclerosis: A Time Trade-Off (TTO) Elicitation Study. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Farid Samaan, Áquilas Mendes, Leonardo Carnut
Privatization and Oligopolies of the Renal Replacement Therapy Sector on Contemporary Capitalism: A Systematic Review and the Brazilian Scenario. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Roberto Bassani, Thibaut Galvain, Suzanne Battaglia, Hendramoorthy Maheswaran, George W J Wright, Ankita Kambli, Alessandra Piemontese
Budget Impact Analysis of Minimally Invasive versus Open Transforaminal Lumbar Interbody Fusion for Lumbar Degenerative Disease: A European Hospital Perspective. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Grace E Fox, Mark Bernauer, Jennifer M Stephens, Bianca Jackson, Joshua A Roth, Ahmed Shelbaya
Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Sergio Di Matteo, Roberto Freilone, Giacomo Matteo Bruno, Rosario Notaro, Sabrin Moumene, Nicoletta Martone, Cristina Teruzzi, Antonio Ciccarone, Giorgio Lorenzo Colombo
Cost-Utility Analysis Comparing Pegcetacoplan to Anti-C5 Monoclonal Antibodies in the Treatment of Paroxysmal Nocturnal Hemoglobinuria. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Julie Marie Akers, Jennifer C Miller, Brandy Seignemartin, Linda Garrelts MacLean, Bidisha Mandal, Clark Kogan
Expanding Access to Patient Care in Community Pharmacies for Minor Illnesses in Washington State. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Ryan Kipp, Lee-Or Herzog, Rahul Khanna, Dongyu Zhang
Racial and Ethnic Differences in Initiation and Discontinuation of Antiarrhythmic Medications in Management of Atrial Fibrillation. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Bhavani Shankara Bagepally, S Sajith Kumar, Akhil Sasidharan
Evaluating Health Expenditure Trends and Disease Burden in India: A Cost per DALY Approach. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Dilek Gogas Yavuz, Omar Akhtar, Kaywei Low, Adrien Gras, Batu Gurser, Esra Safak Yilmaz, Amaury Basse
The Economic Impact of Obesity in Turkey: A Micro-Costing Analysis. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Jithin K Sreedharan, Arun Vijay Subbarayalu, Ajayan Kamalasanan, Ibrahim Albalawi, Gokul Krishna Gopalakrishnan, Ayedh Dhafer Alahmari, Jihad A Alsalamah, Mohammed Ghaithan Alkhathami, Meshal Alenezi, Abdullah S Alqahtani, Mohammed Alahmari, Michael R Phillips, JoAnne MacDonald
Key Performance Indicators: A Framework for Allied Healthcare Educational Institutions. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Malvina Hoxha, Visar Malaj, Bruno Zappacosta, Najada Firza
Pharmacoeconomic Evaluation of Costs of Myelomeningocele and Meningocele Treatment and Screening. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Sukhvinder Johal, Lance Brannman, Victor Genestier, Hélène Cawston
Challenges with Estimating Long-Term Overall Survival in Extensive Stage Small-Cell Lung Cancer: A Validation-Based Case Study. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Ralph H B Benedict, Pamela Vo, Nicholas Adlard, Olwyn Grennan, Ashley Enstone, Daisy Bridge, Robin Wyn, Stanley L Cohan
Disutility of Cognitive Processing Speed (CPS) Impairment in the Context of Multiple Sclerosis: A Time Trade-Off (TTO) Elicitation Study. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Sukhvinder Johal, Lance Brannman, Victor Genestier, Hélène Cawston
Challenges with Estimating Long-Term Overall Survival in Extensive Stage Small-Cell Lung Cancer: A Validation-Based Case Study. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Santi Aprilianti, Auliasari M Utami, Auliya Abdurrohim Suwantika, Neily Zakiyah, Vanji Ikhsan Azis
The Cost-Effectiveness of Dolutegravir in Combination with Tenofovir and Lamivudine for HIV Therapy: A Systematic Review. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Santi Aprilianti, Auliasari M Utami, Auliya Abdurrohim Suwantika, Neily Zakiyah, Vanji Ikhsan Azis
The Cost-Effectiveness of Dolutegravir in Combination with Tenofovir and Lamivudine for HIV Therapy: A Systematic Review. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Farid Samaan, Áquilas Mendes, Leonardo Carnut
Privatization and Oligopolies of the Renal Replacement Therapy Sector on Contemporary Capitalism: A Systematic Review and the Brazilian Scenario. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Jorge Echeverri, Rui Martins, Kai Harenski, J Patrick Kampf, Paul McPherson, Julien Textoris, Jay L Koyner
Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14). ClinicoEconomics and outcomes research : CEOR 16 (2024)
Farid Samaan, Áquilas Mendes, Leonardo Carnut
Privatization and Oligopolies of the Renal Replacement Therapy Sector on Contemporary Capitalism: A Systematic Review and the Brazilian Scenario. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Grace E Fox, Mark Bernauer, Jennifer M Stephens, Bianca Jackson, Joshua A Roth, Ahmed Shelbaya
Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Nigel S B Rawson, David J Stewart
Timeliness of Health Technology Assessments and Price Negotiations for Oncology Drugs in Canada. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Sergio Di Matteo, Roberto Freilone, Giacomo Matteo Bruno, Rosario Notaro, Sabrin Moumene, Nicoletta Martone, Cristina Teruzzi, Antonio Ciccarone, Giorgio Lorenzo Colombo
Cost-Utility Analysis Comparing Pegcetacoplan to Anti-C5 Monoclonal Antibodies in the Treatment of Paroxysmal Nocturnal Hemoglobinuria. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Julie Marie Akers, Jennifer C Miller, Brandy Seignemartin, Linda Garrelts MacLean, Bidisha Mandal, Clark Kogan
Expanding Access to Patient Care in Community Pharmacies for Minor Illnesses in Washington State. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Abdulmajeed Alshowair, Saleh Altamimi, Faisal A Alruhaimi, Saad Alshahrani, Fatima Alsuwailem, Mona Alkhaldi, Haiam Abdalla, Fahad Hamad Alkhuraiji, Montaser Saad Alaqeel, Salman Sulaiman Almureef, Salman Alhawasy, Amro Abdel-Azeem
Cost-Savings Associated with Multi-Disciplinary Team Approach for Reducing Macrovascular and Microvascular Complications in Patients with Type 2 Diabetes: A Predictive Model. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Nigel S B Rawson, David J Stewart
Timeliness of Health Technology Assessments and Price Negotiations for Oncology Drugs in Canada. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Jithin K Sreedharan, Arun Vijay Subbarayalu, Ajayan Kamalasanan, Ibrahim Albalawi, Gokul Krishna Gopalakrishnan, Ayedh Dhafer Alahmari, Jihad A Alsalamah, Mohammed Ghaithan Alkhathami, Meshal Alenezi, Abdullah S Alqahtani, Mohammed Alahmari, Michael R Phillips, JoAnne MacDonald
Key Performance Indicators: A Framework for Allied Healthcare Educational Institutions. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Ryan Kipp, Lee-Or Herzog, Rahul Khanna, Dongyu Zhang
Racial and Ethnic Differences in Initiation and Discontinuation of Antiarrhythmic Medications in Management of Atrial Fibrillation. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Rami A Al-Dwairi, Abdelwahab Aleshawi, Laith Abu-Zreig, Wafa Al-Shorman, Seren Al Beiruti, Ali Omar Alshami, Mohammed Z Allouh
The Economic Burden of Diabetic Retinopathy in Jordan: Cost Analysis and Associated Factors. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Bhavani Shankara Bagepally, S Sajith Kumar, Akhil Sasidharan
Evaluating Health Expenditure Trends and Disease Burden in India: A Cost per DALY Approach. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Kevin C J Yuen, Lewis S Blevins, David R Clemmons, Mads Faurby, Andrew R Hoffman, Nicky Kelepouris, Janice M Kerr, Jens Magelund Tarp, Maria Fleseriu
Medical Costs Associated with High/Moderate/Low Likelihood of Adult Growth Hormone Deficiency: A Healthcare Claims Database Analysis. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Krithika Rajagopalan, Nazia Rashid, Vinod Yakkala, Dilesh Doshi
Analysis of Medicare Patients Treated with Pimavanserin versus Other Atypical Antipsychotics: A Cost-Offset Model Evaluating Skilled Nursing Facility Stays and Long-Term Care Admissions in Parkinson's Disease Psychosis. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Dilek Gogas Yavuz, Omar Akhtar, Kaywei Low, Adrien Gras, Batu Gurser, Esra Safak Yilmaz, Amaury Basse
The Economic Impact of Obesity in Turkey: A Micro-Costing Analysis. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Charles D Burger, Yuen Tsang, Marie Chivers, Riya Vijay Vekaria, Gurinderpal Doad, Nikki Atkins, Sumeet Panjabi
Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Vivek Y Reddy, Yue Zhong, Alysha M McGovern, Stacey L Amorosi, Meghan B Gavaghan, Deanna S Hertz, Kaywei Low, Scott Freeman, David R Holmes
Comparative Costs to Medicare and Medicare Beneficiaries of Alternative AF Stroke Risk Reduction Strategies. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Vivek Y Reddy, Yue Zhong, Alysha M McGovern, Stacey L Amorosi, Meghan B Gavaghan, Deanna S Hertz, Kaywei Low, Scott Freeman, David R Holmes
Comparative Costs to Medicare and Medicare Beneficiaries of Alternative AF Stroke Risk Reduction Strategies. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Charles D Burger, Yuen Tsang, Marie Chivers, Riya Vijay Vekaria, Gurinderpal Doad, Nikki Atkins, Sumeet Panjabi
Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Aladin Aladin, Werry Darta Taifur, Syed Mohamed Aljunid, Dwiana Ocviyanti
Development of an Efficient and Effective Clinical Pathway for Cesarean Section in West Sumatra (Indonesia). ClinicoEconomics and outcomes research : CEOR 16 (2024)
Amrizal Muhammad Nur, Syed Mohamed Aljunid, Mohammad Almari
The Economic Burden of the COVID-19 Pandemic in State of Kuwait. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Jason Robert Guertin, Mahée Gilbert-Ouimet, Michèle Dugas, Valérie Carnovale, Laura Jalbert, Olha Svyntozelska, Juliette Demers, Léonie Matteau, Frédéric Bergeron, Annie LeBlanc
Methods used to account for caregivers' sex and gender within studies examining the financial burden of caregivers of children and adolescents : Results from a scoping review. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Roberto Bassani, Thibaut Galvain, Suzanne Battaglia, Hendramoorthy Maheswaran, George W J Wright, Ankita Kambli, Alessandra Piemontese
Budget Impact Analysis of Minimally Invasive versus Open Transforaminal Lumbar Interbody Fusion for Lumbar Degenerative Disease: A European Hospital Perspective. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Jorge Echeverri, Rui Martins, Kai Harenski, J Patrick Kampf, Paul McPherson, Julien Textoris, Jay L Koyner
Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14). ClinicoEconomics and outcomes research : CEOR 16 (2024)